Showing results (11-20 of 279) with videos related to
Sort By:
Pageof 28
Deutsches Arzteblatt International|October 25, 2012
Acute lymphoblastic leukemia in children: treatment planning via minimal residual disease assessmentClaus R Bartram, André Schrauder, Rolf Köhler, et al.Blood|August 17, 2012
How I treat relapsed childhood acute lymphoblastic leukemiaFranco Locatelli, Martin Schrappe, Maria Ester Bernardo, et al.Haematologica|November 11, 2003
Protein expression of the glucocorticoid receptor in childhood acute lymphoblastic leukemiaMelchior Lauten, Gunnar Cario, Girmay Asgedom, et al.Hematology. American Society of Hematology. Education Program|November 25, 2004
Childhood and adolescent lymphoid and myeloid leukemiaChing-Hon Pui, Martin Schrappe, Raul C Ribeiro, et al.Oncoimmunology|September 18, 2018
Perspectives of Fc engineered antibodies in CD19 targeting immunotherapies in pediatric B-cell precursor acute lymphoblastic leukemiaChristian Kellner, Matthias Peipp, Martin Gramatzki, et al.Pediatric Hematology and Oncology|January 1, 2005
Acute lymphoblastic leukemia and Klinefelter syndrome in children: two cases and review of the literatureJan-Nicolas Machatschek, André Schrauder, Frank Helm, et al.Current Opinion in Oncology|February 6, 2013
Optimizing asparaginase therapy for acute lymphoblastic leukemiaCarmelo Rizzari, Valentino Conter, Jan Starý, et al.Medical and Pediatric Oncology|January 9, 2003
A prospective study of minimally invasive techniques in pediatric surgical oncology: preliminary reportSteven Warmann, Jörg Fuchs, Nathalie K Jesch, et al.Medical and Pediatric Oncology|October 12, 2002
Mediastinal mass in childhood T-cell acute lymphoblastic leukemia: significance and therapy responseAndishe Attarbaschi, Georg Mann, Michael Dworzak, et al.Pediatric Blood & Cancer|October 30, 2004
Osteonecrosis: a treatment related toxicity in childhood acute lymphoblastic leukemia (ALL)--experiences from trial ALL-BFM 95Britta Bürger, Rita Beier, Martin Zimmermann, et al.Pageof 28